
Overview
I realized during a biology class in college that I could use my interest in science to help make a difference in people’s lives. It drove my decision to pursue a career in medicine. I realized early in medical school that I wanted to spend my career trying to understand cancer, how to fight it and caring for patients who have it. As a medical oncologist with Duke Cancer Center, I specialize in cancers of the chest, including lung cancer and mesothelioma. Working closely with my patients, getting to know them personally and understanding their values and goals, allows me to develop individualized care and treatment plans for each one. The most rewarding part of my work is developing long term relationships with my patients and their families throughout their cancer journeys. I am motivated and inspired by how my patients live their lives everyday.
Dr. Melson-Clarke is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Large-Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Duke Medicine Cir, Durham, NC 27710
6301 Herndon Rd, Durham, NC 27713
Additional Areas of Focus
Dr. Melson-Clarke has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Duke Cancer Center Brain Tumor Clinic
My clinical practice if focused on the care of patients with breast cancer, particularly those diagnosed at a younger age and those with recurrence in the central nervous system. I am committed to the care of patients with breast cancer brain metastases, and I am honored to serve as the Medical Director of the Brain and Spine Metastases Program in the Duke Cancer Center. In this role, our multidisciplinary team provides well-coordinated care for patients with breast cancer and other solid tumor types that have metastasized to the central nervous system. In addition, I enjoy helping young women diagnosed with breast cancer navigate their treatment decisions to ensure both excellent medical care and attention to individual challenges, such as future fertility, sequelae of treatment on longer-term health, and impact on current and future relationships. When not working, I enjoy running, reading, and traveling with my family. Dr. Anders is rated as an Elite provider by MediFind in the treatment of Metastatic Brain Tumor. Her top areas of expertise are Breast Cancer, Brain Tumor, Triple-Negative Breast Cancer, and Metastatic Brain Tumor.
Duke Cancer Center Brain Tumor Clinic
I am an academic adult and pediatric neuro-oncologist who helps lead The Preston Robert Tisch Brain Tumor Center at Duke. I am the author of more than 500 peer-reviewed articles, reviews, and book chapters, and I have presented extensively at both international and national meetings. I am a committed educator who is a member of the executive and super-executive committees of the Duke University School of Medicine, which are responsible for the recruitment, screening and selection of medical students. I have reviewed grants for the National Institutes of Health for over 15 years, in a spectrum of different study sections. I am the senior editor of CNS Oncology and a reviewer for over 25 academic journals. I serve on the advisory board of a number of organizations, including Voices Against Brain Cancer, the Tug McGraw Foundation, Pinnacle Care, the Pediatric Brain Tumor Foundation, the National Children’s Cancer Society, and the American Brain Tumor Association. Dr. Friedman is rated as an Elite provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Brain Tumor.
Duke Cancer Center
As a cancer doctor, I strive to provide the kind of care that I would want for my own family. My aim is to use my expertise, knowledge, and understanding of the human condition to empower patients. While scientific knowledge and approaches are at the core of what I do, I find it important to aim to integrate the human context into what my team and I offer patients and their families. Having lived, trained, and worked in different countries, including Australia, the United Kingdom, the Netherlands, and the United States, I have developed unique insights into the practice of medicine and cancer care around the world. These experiences have given me a broader perspective and helped inform my approach to individualized patient care. I see my ability to help patients as a privilege, and I do get enormous pleasure from being able to help. When not working, I am an avid reader and enjoy running, cycling, and spending time with my family. Dr. Khasraw is rated as an Elite provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Hip Replacement.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Melson-Clarke isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Melson-Clarke isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Melson-Clarke isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Melson-Clarke isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Melson-Clarke isDistinguished. Learn about Lung Cancer.
- MesotheliomaDr. Melson-Clarke isDistinguished. Learn about Mesothelioma.
- Advanced
- Metastatic Brain TumorDr. Melson-Clarke isAdvanced. Learn about Metastatic Brain Tumor.
- Metastatic Pleural TumorDr. Melson-Clarke isAdvanced. Learn about Metastatic Pleural Tumor.
- Posterior Fossa TumorDr. Melson-Clarke isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Melson-Clarke isAdvanced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Experienced
- Lung NodulesDr. Melson-Clarke isExperienced. Learn about Lung Nodules.
- Lymphofollicular HyperplasiaDr. Melson-Clarke isExperienced. Learn about Lymphofollicular Hyperplasia.
- Neuroendocrine TumorDr. Melson-Clarke isExperienced. Learn about Neuroendocrine Tumor.
- Thymic Epithelial TumorDr. Melson-Clarke isExperienced. Learn about Thymic Epithelial Tumor.



